The cloned murine cytolytic T-lymphocyte line TEl-IL and several sublines detect a murine cytomegalovirus immediate-early (IE) membrane determinant in conjunction with Ld class I major histocompatibility glycoprotein. The lines retained cytolytic activity, strict antigen specificity, and self-restriction even when adapted to long-term, antigen-independent growth in the presence of interleukin-2 only (M. J. Reddehase, H.-J. Buhring, and U. H. Koszinowski, J. Virol. 57:408412). These Members of the herpesvirus family such as herpes simplex viruses, varicella zoster virus, Epstein-Barr virus, and cytomegalovirus (CMV) establish latency in the immunocompetent host, but can cause fatal disease in cases of immunosuppression (17). Murine CMV (MCMV) infection has proven a convenient model to investigate aspects of herpesvirus latency (2, 6), recurrency (10, 15), pathogenesis (3, 4, 25, 27), and immunity (20, 22) in the natural host.
The cloned murine cytolytic T-lymphocyte line TEl-IL and several sublines detect a murine cytomegalovirus immediate-early (IE) membrane determinant in conjunction with Ld class I major histocompatibility glycoprotein. The lines retained cytolytic activity, strict antigen specificity, and self-restriction even when adapted to long-term, antigen-independent growth in the presence of interleukin-2 only (M. J. Reddehase, H.-J. Buhring, and U. H. Koszinowski, J. Virol. 57:408412). These attributes allowed us to use TEl-IL as a stable, monospecific probe for tracing the expression of the IE membrane antigen throughout the viral replication cycle. Presentation of the antigen at the cell membrane proved to be most effective when expression of IE genes in infected mouse embryo fibroblasts was selectively enhanced by consecutive cycloheximideactinomycin D treatment, whereas without enhancement high numbers of TEl-IL cytolytic T lymphocytes were required to demonstrate the antigen in the IE phase. In the early phase of infection when IE genes were no longer transcribed, cytolysis was not observed, although IE proteins were detectable in the nuclei of the infected cells. Without application of inhibitors IE membrane antigen expression was most prominent during the late phase of infection. Reinitiation of transcription from the genomic region encoding the major IE protein (pp89) and de novo synthesis of pp89 correlated with this reexpression of the IE membrane antigen.
Members of the herpesvirus family such as herpes simplex viruses, varicella zoster virus, Epstein-Barr virus, and cytomegalovirus (CMV) establish latency in the immunocompetent host, but can cause fatal disease in cases of immunosuppression (17) . Murine CMV (MCMV) infection has proven a convenient model to investigate aspects of herpesvirus latency (2, 6) , recurrency (10, 15) , pathogenesis (3, 4, 25, 27) , and immunity (20, 22) in the natural host.
The replication cycle of herpesviruses can be divided into three phases of coordinately regulated expression of genes: the immediate-early (IE; a) phase, the early (,B) phase, and the late (y) phase (9, 11, 31) . A result not anticipated by previous studies with other herpesviruses was the finding that IE genes, the first viral genes transcribed after infection of permissive cells, not only encode regulatory intracellular proteins essential for viral replication, but also specify a membrane antigen which serves as a target structure for MCMV-specific cytolytic T lymphocytes (CTL) (23, 24) . The predominant IE gene product of MCMV, a trans-activating 89,000-dalton (89K) phosphoprotein (pp89) located mainly in the nucleus of the infected cell, is encoded by gene iel, which is controlled by a strong transcriptional enhancer (5, 12, 14) . Although MCMV virions are composed of many different structural polypeptides including six glycoproteins (13) , most CTL sensitized during acute infection of mice were found to recognize target cells after selective enhancement of IE gene transcription (24) . Beyond the IE phase, in the presence of a multitude of proteins specified by MCMV, IE membrane antigens cannot be discriminated from other antigens with a polyclonal CTL population as probe. To trace the presence of a particular IE membrane antigen throughout the viral replication cycle, we have now used the * Corresponding author.
cloned CTL line IEl-IL (Lyt-2.2+, L3T4-, Ld restricted) that defines the antigenic determinant IE1 (21) . Data demonstrate that expression of target antigen is mainly a latephase event that correlates with reexpression of the major IE gene.
As anticipated by previous studies (21, 23, 24) , the IE membrane antigen was detected when the expression of IE genes was enhanced by infection in the presence of cycloheximide. After a period of selective transcription, cycloheximide was replaced by actinomycin D (ActD) to allow translation of accumulated IE transcripts and to prevent transcription of early-phase genes (Fig. 1 , column A, closed circles). This protocol also excluded induction of cellular antigens by pp89-mediated transcriptional activation. The antigen was not detectable when the same amount of virus, inactivated by UV light, was used for mock infection (column A, squares). This control ensured that the antigen recognized by clone IE1 was not a virion structural antigen or a cellular antigen induced by virion protein, by inhibitor treatment, or by an interaction of both. With another CTL clone, clone Si, a structural antigen can be detected on this type of target cell (21) .
Consistent with previous observations using polyclonal CTL (23), lysis was barely detectable during the IE phase when the expression of IE genes was not enhanced (Fig. 1,  column B) . At the multiplicity of infection used thrQughout this experiment, 2 PFU of MCMV per cell, 80 to 90% of fibroblasts displayed intranuclear pp89 during all phases as identified with monoclonal antibody MCMV-6/58/1 [immunoglobulin G2b (K)] by indirect immunofluorescence. It should be noted that the observed low level of IE membrane antigen expression during the IE phase could not be elevated by raising the multiplicity of infection (data not shown). In contrast, lysis was more pronounced, in particular when
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cloned CTL line IEI-IL (Lyt-2.2+, L3T4-, L d restricted) that defines the antigenic determinant lEI (21) . Data demonstrate that expression of target antigen is mainly a latephase event that correlates with reexpression of the major IE gene.
As anticipated by previous studies (21, 23, 24) , the IE membrane antigen was detected when the expression of IE genes was enhanced by infection in the presence of cycloheximide. Mter aperiod of selective transcription, cycloheximide was replaced by actinomycin D (ActD) to allow translation of accumulated IE transcripts and to pr~vent transcription of early-phase genes (Fig. 1 , column A, closed circles). This protocol also excluded induction of cellular antigens by pp89-mediated transcriptional activation. The antigen was not detectable when the same amount of virus, inactivated by UV light, was used for mock infection (column A, squares). This control ensured that the antigen recognized by clone lEI was not a virion structural antigen or a cellular antigen induced by virion protein, by inhibitor treatment, or by an interaction of both. With another CTL clone, clone SI, a structural antigen can be detected on this type of target cell (21) .
Consistent with previous observations using polyclonal CTL (23), lysis was barely detectable during the IE phase when the expression of IE genes was not enhanced (Fig. 1,  column B) . At the multiplicity of infection used thrQughout this experiment, 2 PFU of MCMV per cell, 80 to 90% of fibroblasts displayed intranuclear pp89 during all phases as identified with monoclonal antibody MCMV-6/58/I [immunoglobulin G2b (K)] by indirect immunoftuorescence. It should be noted that the observed low level of IE membrane antigen expression during the IE phase could not be elevated by raising the multiplicity of infection (data not shown). In contrast, lysis was more pronounced, in particular when effector/target cell ratios are considered, during the late phase of infection (column C). This finding showed for the first time that IE membrane antigen is expressed in an amount sufficient for CTL effector function under conditions not influenced by application of inhibitors. Similar to the synthesis of most -y gene products, the presentation of the IEl epitope during the late phase could be prevented by infection in the presence of the DNA synthesis inhibitor phosphonoacetic acid (PAA; column D), while presentation of the same epitope after selective enhanced expression of IE genes was not affected by PAA (column A, open circles). These results demonstrated that the IE membrane antigen was absent during the early phase (column D) and implied that synthesis of the late-phase IE membrane antigen also dated from the late phase.
Since the IE membrane antigen is composed of the viral IE1 determinant and the cellular Ld glycoprotein encoded by the major histocompatibility complex, absence or presence of the compound antigen could reflect the temporal expression of either component. The expression of Ld antigen during the early and late phases of infection was therefore analyzed with an Ld_specific cloned CTL line referred to as B6aLd (Table 1 ). This line was derived by cloning from the polyclonal population of C57BL/6 anti-BALB/c CTL already used in a previous report (21) . Specificity mapping for line B6aLd is demonstrated in Table 1 , experiment 1. The data shown in Table 1 , experiment 2, revealed no significant difference in the expression of Ld between noninfected fibroblasts and fibroblasts during the early or late phase of MCMV replication, but again, the IE membrane antigen was detected during the late phase. Superinfection by virions released during the late phase must be discussed as one possible explanation for this observation. Three findings, however, are not consistent with that interpretation. First, as already mentioned above, raising the multiplicity of infection under IE conditions did not result in more pronounced lysis of target cells by clone IEL. It is therefore not likely that superinfection at a later stage would cause enhanced expression of the IE membrane antigen. Second, production and release of virions in the late phase did not enhance the susceptibility of target cells to lysis by CTL clone S1 (not shown), although this clone has been shown previously to detect, in a dose-dependent manner, a viral structural antigen integrated into the target cell membrane from without during the penetration step of infection (21) . Third, the IE membrane antigen was found to be expressed in the late phase also when significant release of infectious virus was prevented by halting late-phase transcription with ActD (Table 1) . Enhanced expression of the IE membrane antigen during the late phase can therefore not be explained by superinfection.
Altogether, the viral determinant TEl was found to be reexpressed in the late phase and thus predicted reexpression of a viral IE gene during the late phase, presumably due to transcription of the gene from an increased number of templates.
That was indeed the case, as shown by a nuclear run-on transcription assay (8) (Fig. 2A) . RNA synthesized in nuclei isolated at different times during the viral replication cycle was hybridized to iel sequences contained in plasmid pIE110 (14) as the specific probe and to vector pSP62 DNA (16) for control. Transcription from the genomic region represented by pIE110 was detectable during the IE phase (a; 1 h postinfection [p.i.]), ceased during the early phase (,B; 8 h p.i.), and was initiated again in the beginning late phase (Y16; 16 h p.i.) (11) , increasing with time (Y24; 24 h p.i.). , MCMV was inactivated with UV light as described previously (24) . Fibroblasts in the late phase of infection were assayed 24 h p.i. (column C). For each of the indicated effector/target cell ratios (1,000 51Cr-labeled target cells), specific lysis was determined in six replicates in a standard 3-h 51Cr-release assay. Mean values are normalized to the maximum specific lysis observed (46% at effector/target cell ratio of 10; column A, closed circle). The dashed lines represent the upper 95% confidence limit of spontaneous lysis.
Transcription unrelated to gene iel from a putative late gene on the opposite strand might have contributed to the signal in the run-on assay, but reexpression of gene iel was proved by Northern blot hybridization revealing the 2.75-kilobase RNA that specifies pp89 (not shown), and immunoprecipitation of proteins biosynthetically labeled during the late phase (20 to 24 h p.i.) positively identified pp89 as one of the proteins synthesized in the late phase (Fig. 2B) . Several late-phase polypeptides could be precipitated with immune serum, including an 89K protein (lane-a) that was identified as pp89 by precipitation with specific monoclonal antibody (lane b). The synthesis of late-phase proteins, including late synthesized pp89, was inhibited (lanes c and d) when infection was performed in the presence of PAA. This result confirmed that viral DNA synthesis is required for reexpression of pp89.
In conclusion, although intranuclear pp89 could be de-effector/target cell ratios are considered, during the late phase of infection (column C). This finding showed for the first time that JE membrane antigen is expressed in an amount sufficient for CTL effector function under conditions not inftuenced by application of inhibitors. Similar to the synthesis of most "( gene products, the presentation of the JEI epitope during the late phase could be prevented by infection in the presence of the DNA synthesis inhibitor phosphonoacetic acid (PAA; column D), while presentation of the same epitope after selective enhanced expression of JE genes was not affected by PAA (column A, open circles) . These results demonstrated that the JE membrane antigen was absent during the early phase (column D) and implied that synthesis of the late-phase JE membrane antigen also dated from the late phase.
Since the JE membrane antigen is composed of the viral JEl determinant and the cellular L d glycoprotein encoded by the major histocompatibility complex, absence or presence of the compoj.lnd antigen could reftect the temporal expression of either component. The expression of L d antigen during the early and late phases of infection was therefore analyzed with an L d-specific cloned CTL li ne referred to as B6aL d (Table 1 ). This line was derived by cloning from the polyclonal population ofC57BL/6 anti-BALB/c CTL already used in a previous report (21) Table 1 , experiment 1. The data shown in Table 1 , experiment 2, revealed no significant difference in the expression of L d between noninfected fibroblasts and fibroblasts during the early or late phase of MCMV replication, but again, the JE membrane antigen was detected during the late phase. Superinfection by virions released during the late phase must be discussed as one possible explanation for this observation. Three findings, however, are not consistent with that interpretation. First, as already mentioned above, raising the multiplicity of infection under JE conditions did not result in more pronounced lysis of target cells by clone JE1. It is therefore not likely that superinfection at a later stage would cause enhanced expression of the IE membrane antigen. Second, production and release of virions in the late phase did not enhance the susceptibility of target cells to lysis by CTL clone SI (not shown), although this clone has been shown previously to detect, in ~ dose-dependent manner, a viral structural antigen integrated into the target cell membrane from without during the penetration step of infection (21) . Third, the JE membrane antigen was found to be expressed in the late phase also when significant release of infectiom; virus was prevented by halting late-phase transcription with ActD (Table 1) . Enhanced expression of the IE membrane antigen during the late phase can therefore not be explained by superinfection.
Altogether, the viral oeterminant lEI was found to be reexpressed in the late phase and thus predicted reexpression of a viral JE gene during the late phase, presumably due to transcription of the gene from an increased number of templates.
That was indeed the case, as shown by a nuclear run-on transcription assay (8) (Fig. 2A) . RNA synthesized in nuclei isolated at different times during the viral replication cycle was hybridized to ie! sequences contained in plasmid plEllO (14) as the specific probe and to vector pSP62 DNA (16) (24) . Fibroblasts in the late phase of infection were assayed 24 h p.i. (column C). For each of the indicated effectpr/target cell ratios (1,000 51Cr-labeled target cells), specific lysis was determined in six replicates in a standard 3-h 51Cr-release assay. Mean values are normalized to the maximum specific lysis observed (46% at effector/target cell ratio of 10; column A, closed circle). The dashed lines represent the upper 95% confidence limit of spop.taneous lysis.
Transcriptjon unrelated to gene iel from a putative late gene on the opposite strand might have contributed to the signal in the run-on assay, but reexpression of gene ieI was pfoved by Northem blot hybridization revealing the 2.75-kilobase RN A that specifies pp89 (not shown), and immunoprecipitation of proteins piosynthetically labeled duripg the late phase (20 to 24 h p.i.) positively identified pp89 as one of the proteins synt~esized in the late phase (Fig. 2B) . Severallate-phase polypeptides could be precipitated with immune serum, including an 89K protein (lane -a) that was identified as pp89. by precipitation with specific monoclonal antib6dy (lane b). The synthesis of late-phase proteins, including late synthesiz~d pp89, was irthibited (lanes c and d) when infection was perfofllled in the presence of P AA. This result confirmed that viral DNA synthesis is required for reexpression of pp89.
In conclusion, although intranuclear pp89 could be de- Recent findings in vital immunology converge to the conclusion that viral genes which do not code for classical cell membrane glycoproteins, but for proteins located mainly in the nucleus of the infected cell, specify immunodominant determinants recognized by CTL in conjunction with class I major histocompatibility glycoprotein. Prominent examples are the nonstructural large-T antigen of the papovavirus simian virus 40 (18, 28) and the internal virion nucleoprotein of the myxovirus influenza A (29, 30, 33) . These viruses encode only a low number of proteins. Considering the high coding capacity of MCMV (7), it is remarkable that the same principle appears to rule the CTL response to this virus (21, 23, 24) . Analysis of the organization of the MCMV IE region has revealed minor IE gene products besides the by far most abundantly synthesized pp89 encoded by gene iel (G. M. Keil tected with monoclonal antibody during all phases, the IE membrane antigen was not detectabie during the early phase when gene iel was hot transcribed, but was detectable in the late phase when expression of gene iel was reinitiated. These conditions have two important implications. First, presentation of IE target antigen is not correlated with intranuclear presence of the major IE protein, but rather with its synthesis, and second, infected fibroblasts are susceptible to lysis by IE-specific CTL mainly during the late phase of viral. replication.
Recent findings in vital immunology converge to the conclusion that viral genes which do not code for classical cell membrane glycoproteins, but for proteins located mainly in the nucleus of the infected cell, specify immunodominant determinants recognized by CTL in conjunction with class I major histocompatibility glycoprotein. Prominent examples are the nonstructural large-T antigen of the papovavirus simian virus 40 (18, 28) and the internal virion nucleoprotein of the myxovirus influenza A (29, 30, 33) . These viruses encode only a low number of proteins. Considering the high coding capacity of MCMV (7), it is remarkable that the same principleappears to rule the C,TL response to this vinis (21, 23, 24) . Analysis ofthe organization ofthe MCMV IE region has revealed minor IE gene products besides the by far most abundantly synthesized pp89 encoded by gene iel (G. M. expression is among these minor proteins, or whether the intranuclear pp89 itself is degraded to antigenic peptides presented at the cell membrane in a mode similar to that postulated for influenza A nucleoprotein (29, 30) , remains to be investigated.
While the presence of a regulatory IE protein during the y phase has been reported for herpes simplex virus type 1 (32) , the coincidence of a gene reexpression and presentation of an IE target antigen for CTL during the y phase of MCMV infection is a new finding relevant to immune surveillance.
In a previous communication we postulated sites of preferential IE gene expression to explain the high frequency of IE-specific CTL (24) . Since fibroblasts display only class I major histocompatibility antigen, efficient in vivo induction of an IE-specific CTL response also predicts cells that present IE membrane antigen in association with class II major histocompatibility antigen. Recent investigations have identified monocytes and lymphocytes as sites where, in fact, replication of human CMV is restricted to expression of IE genes (26) . Whether these cells also present an IE antigen at the cell membrane and whether CTL that recognize human CMV-infected cells at early times in the replication cycle (1) are directed specifically to an IE membrane antigen await further analysis.
The regulatory function of IE proteins implies that transcription of (x genes is a decisive step in virus reactivation from latency. IE antigen-specific memory CTL (23) are candidates to counteract recurrency in its initial phase. At first glance, the finding that CTL effector function appears to be executed mainly during the late phase seems to be inconsistent with that predicted role of CTL. Two arguments, however, have to be considered. First, antigen presentation in permissive fibroblasts infected in vitro is not necessarily representative of other cell types and antigen presentation in vivo. Second, when taking into account the dynamics of the protracted replication cycle of CMVs, the kinetics of IE membrane antigen expression observed in fibroblasts could indeed promote the function of IE-specific CTL. If we speculate that a low level of antigen expression is sufficient for in vivo sensitization of memory CTL already during the IE phase, the generated effector CTL could deliver the lethal hit during the late phase to the same cells by which they have been triggered. In a previous communication we postulated sites of preferential IE gene expression to explain the high frequency of IE-specific CTL (24) . Since fibroblasts display only class I major histocompatibility antigen, efficient in vivo induction of an IE-specific CTL response also predicts cells that present IE membrane antigen in association with class 11 major histocompatibility antigen. Recent investigations have identified monocytes and lymphocytes as sites where, in fact, replication of human CMV is restricted to expression of IE genes (26) . Whether these cells also present an IE antigen at the cell membrane and whether CTL that recognize human CMV -infected cells at early times in the replication cycle (1) are directed specifically to an IE membrane antigen await further analysis.
The regulatory function of IE proteins implies that transcription of a genes is a decisive step in virus reactivation from latency. IE antigen-specific memory CTL (23) are candidates to counteract recurrency in its initial phase. At first glance, the finding that CTL etfector function appears to be executed mainly during the late phase seems to be inconsistent with that predicted role of CTL. Two arguments, however, have to be considered. First, antigen presentation in permissive fibroblasts infected in vitro is hot necessarily representative öf other cell types and antigen presentation in vivo. Second, when taking into account the dynamics of the protracted replication cycle of CMVs, the kinetics of IE membrane antigen expression observed in fibroblasts could indeed promote the function of IE-specific CTL. If we speculate that a low level of antigen expression is sufficient for in vivo sensitization of memory CTL already during the IE phase, the generated etfector CTL could deliver the lethal hit during the late phase to the same cells by which they have been triggered.
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